Cargando…
Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study
Autores principales: | Zhu, Xueling, Liu, Xiang, Wan, Zhikai, Hui, Jiangjin, Tao, Ran, Peng, Xiaorong, Su, Junwei, Huang, Ying, Zhu, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685422/ https://www.ncbi.nlm.nih.gov/pubmed/37882105 http://dx.doi.org/10.1097/CM9.0000000000002883 |
Ejemplares similares
-
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study
por: Wan, Zhikai, et al.
Publicado: (2023) -
Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study
por: Liu, Xiang, et al.
Publicado: (2022) -
HIV-associated dyslipidemia: pathogenesis and its management
por: Wan, Zhikai, et al.
Publicado: (2023) -
Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China
por: Wan, Zhikai, et al.
Publicado: (2023) -
Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV”
por: Lombardi, Andrea, et al.
Publicado: (2023)